Lorcaserin: Real World Experience in an Insurance-Based Weight Management Clinic
Status: | Active, not recruiting |
---|---|
Conditions: | Obesity Weight Loss, Obesity Weight Loss |
Therapuetic Areas: | Endocrinology |
Healthy: | No |
Age Range: | 18 - Any |
Updated: | 6/13/2018 |
Start Date: | April 11, 2017 |
End Date: | April 11, 2019 |
Real World Experience With Lorcaserin for Weight Management
This is a retrospective, descriptive study that involves de-identified data consisting of
weight changes, pertinent vital signs and laboratory values influenced by body weight, and
healthcare utilization of patients prescribed lorcaserin at The Center for Weight Management
at the Scripps Clinic in San Diego, CA.
weight changes, pertinent vital signs and laboratory values influenced by body weight, and
healthcare utilization of patients prescribed lorcaserin at The Center for Weight Management
at the Scripps Clinic in San Diego, CA.
All patients who initiated treatment with Lorcaserin during the review period will undergo
chart review. The primary endpoint will be weight change in patients on Lorcaserin and
average duration of Lorcaserin treatment over time (up to 1 year). Secondary endpoints will
include changes in vital signs, liver function, glucose, and lipids. In addition, time on
treatment, reasons for discontinuation of medication, and changes in healthcare utilization
(to include inpatient and outpatient utilization) will be examined. This is a retrospective,
one-arm observational study that will include chart reviews of 157 patients who have been
treated in the clinic.
chart review. The primary endpoint will be weight change in patients on Lorcaserin and
average duration of Lorcaserin treatment over time (up to 1 year). Secondary endpoints will
include changes in vital signs, liver function, glucose, and lipids. In addition, time on
treatment, reasons for discontinuation of medication, and changes in healthcare utilization
(to include inpatient and outpatient utilization) will be examined. This is a retrospective,
one-arm observational study that will include chart reviews of 157 patients who have been
treated in the clinic.
Inclusion Criteria:
- Received at least one prescription for Lorcaserin treatment
- At least 18 years of age or with guardian/parent able to consent for a minor
Exclusion Criteria:
- Patient under the age of 18 at time of index date
We found this trial at
1
site
Click here to add this to my saved trials